This inventor holds 40 USPTO granted patents and 21 published patent applications, plus 4 CIPO patents and 16 EPO patents, primarily in Chimeric Antigen Receptors. Top assignees: Novartis Ag, University of Pennsylvania, University of Pittsburgh. Active years: 2016-2026.
Location History:
- Cambridge, MA (US) (2016 - 2023)
- Sudbury, MA (US) (2016 - 2024)
Company Filing History:
38 out of 3,973 
30 out of 2,645 
4 out of 1,957 
Years Active: 2016-2026
Areas of Expertise:
Title: Jennifer Brogdon: Pioneering Innovations in the Field of Biotechnology
Introduction:
Jennifer Brogdon, a visionary inventor hailing from Sudbury, MA, has made a significant mark in the world of inventors with her relentless pursuit of innovation and remarkable creativity. Her work continues to inspire and shape the future of technology, particularly in the realm of biotechnology.
Latest Patents:
Jennifer Brogdon's latest patents showcase her groundbreaking contributions to the field of medicine and biotechnology. One of her notable inventions is the development of nucleic acid molecules encoding chimeric antigen receptors with a CD20 binding domain. These compositions and methods have paved the way for novel approaches in treating diseases associated with CD20 or CD22 expression, such as certain types of cancer.
Another significant patent by Jennifer Brogdon focuses on a method for treating cancer by administering immune effector cells expressing a chimeric antigen receptor comprising a CD20 binding domain. This innovative approach highlights her commitment to advancing therapeutic interventions in the fight against cancer and other related diseases.
Career Highlights:
Throughout her illustrious career, Jennifer Brogdon has made invaluable contributions at esteemed organizations such as Novartis AG and the University of Pennsylvania. Her innovative research and dedicated work have been instrumental in shaping the landscape of biotechnology and medical advancements.
Collaborations:
Jennifer Brogdon's collaborative spirit is evident through her work with esteemed colleagues such as Andreas Loew and Carl H June. These partnerships have facilitated the exchange of ideas, leading to groundbreaking discoveries and advancements in the field of biotechnology.
Conclusion:
In conclusion, Jennifer Brogdon's unwavering dedication to innovation and her pioneering spirit have solidified her position as a standout figure in the world of inventors. Her remarkable contributions continue to push the boundaries of technology and inspire future generations of inventors.